Sarah Long - Comments

Latest Comments
VBI Vaccines – The Leading Product In The Race For A $3 Billion Market
7 years ago

This article is a good read because I've worked with a lot of special needs children over the years. No one can ever really predict CMV or down syndrome while the baby is developing in the mother, however for CMV it's apparent in the few short years after birth. The children do have a harder time learning in the classroom, and usually have some sort of autism. If the biotech world can help these children earlier in life, to rid this world of cancer, and other birth defects just imagine what this world could look like? It's definitely an exciting topic to follow for the years to come.

In this article: VBIV
1 to 1 of 1 comments

Following (0)

Followers (0)

Stocks I follow

General Stats

Article Comments

Received: 0
Created: 0